Publications by authors named "Marjolein Geurts"

Claim this Profile
G
Genomic distinctions in adolescent and young adult cancer: A comprehensive review.
Jeffrey van Putten, Lina H Lankhorst, Adrianus Johannes de Langen, Anthonie J van der Wekken, Jeanine Roodhart, Marjolein Geurts

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian Adaptive Randomized Trial of Blended Cognitive Behavioral Therapy for Severe Fatigue in Stable Diffuse Glioma.
Maxine Gorter, Jantine G Röttgering, Vera Belgers, Marieke E C Blom, Brigit Thomassen, Marjolein Geurts

Neuro Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell immunity in glioma and potential implications for immunotherapy: a systematic review.
Rosa Luning, Pim J French, Wouter J F Vanbilloen, Lisa Dobber, Levi Van Hijfte, Marjolein Geurts

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlative studies in central nervous system tumors clinical trials: The emerging role of microbiome research.
Raoull Hoogendijk, Marjolein Geurts, Jasper van der Lugt

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas.
Sebastien Perreault, Marjolein Geurts, Jasia Mahdi, Karisa C Schreck, Matthias Preusser

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating Targeted Therapy Into Neuro-Oncology Practice.
Marjolein Geurts, Juan B Blaquier, Maarten Wijnenga, David O Kamson, Macarena I de la Fuente

Am Soc Clin Oncol Educ Book· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real-world cohort study.
Robin W van Steenhoven, Saan Salih, Juna M de Vries, Ide Smets, Rob M Verdijk, Marjolein Geurts, Corine H GeurtsvanKessel

Ann Clin Transl Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?
Marjolein Geurts, Luzia Berchtold, Franz Koenig, Burt Nabors, David A Reardon

Neurooncol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1.
Martin J van den Bent, Enrico Franceschi, Mehdi Touat, Pim J French, Ahmed Idbaih, Marjolein Geurts

Neuro Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations.
Katherine B Peters, Marjolein Geurts

Neurooncol Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma.
Levi van Hijfte, Marjolein Geurts, Iris de Heer, Santoesha A Ghisai, Hayri E Balcioglu

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A brave new framework for glioma drug development.
Kelly M Hotchkiss, Philipp Karschnia, Karisa C Schreck, Marjolein Geurts, Timothy F Cloughesy

Lancet Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empowering the next generation in neuro-oncology: Introduction of the EANO Career Boost Initiative.
Philipp Lohmann, Johnny Duerinck, Matthijs van der Meulen, Dan Mitrea, Susan Short, Marjolein Geurts

Neurooncol Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent glioblastoma in national guidelines on the diagnosis and treatment of gliomas: A matter of European practice variation.
Mark P van Opijnen, Rob J A Nabuurs, Filip Y F de Vos, Mohini T R Ramsoedh, Joost J C Verhoeff, Marjolein Geurts

Brain Spine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.
Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marjolein Geurts, Sybren L N Maas

Med Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor growth in recurrent glioblastoma-RANO: when to plan the baseline scan?
Lisa Dobber, Marjolein Geurts, Martin J van den Bent

Neuro Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?
Marjolein Geurts, Matthias Preusser

Neuro Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse infiltrating tumour with the molecular profile of an atypical teratoid rhabdoid tumour (AT/RT SHH-1B) in an adult patient.
Fleur Cordier, Joost W Schouten, Marjolein Geurts, Johan M Kros, Hendrikus J Dubbink

Neuropathol Appl Neurobiol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.
Lauren R Schaff, Maria Ioannou, Marjolein Geurts, Martin J van den Bent, Ingo K Mellinghoff

Am Soc Clin Oncol Educ Book· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions.
Martin van den Bent, Amanda M Saratsis, Marjolein Geurts, Enrico Franceschi

Neuro Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative.
Emilie Le Rhun, Florien Boele, Giuseppe Minniti, Norbert Galldiks, Martin Taphoorn, Marjolein Geurts

Neurooncol Pract· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?
Matthias Preusser, Marjolein Geurts, Johannes A Hainfellner, Martin J van den Bent

Neuro Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Kirit Singh, Kelly M Hotchkiss, Ian F Parney, John De Groot, Solmaz Sahebjam, Marjolein Geurts

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary brain tumours in adults.
Martin J van den Bent, Marjolein Geurts, Pim J French, Marion Smits, David Capper

Lancet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data.
Levi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, Paul H C Eilers, Peter A E Sillevis Smitt

iScience· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis